Specialties
Reports that name this provider
- IVF Quality in Japan
- Achieved early IVF success in 1984.
- Psilocybin Treatment Legality in Japan
- Dr. Hiroyuki Uchida, Chair and Professor at Department of Neuropsychiatry, leading first clinical trial of psilocybin therapy in Asia in 21st century. AMED-funded trial UMIN000052401 with 12 participants in follow-up phase opened January 2025. IRB approval September 25, 2023. Partnership with Otsuka Pharmaceutical announced May 8, 2025 to build regulatory and clinical infrastructure for psychedelic therapies.
- Specialized Diagnostics in Japan
- Academic hospital with established capabilities in laryngoscopy, caloric vestibular testing, and hearing assessment
- Stem Cell Therapy Quality in Japan
- Spinal cord injury program led by Masaya Nakamura and Hideyuki Okano; demonstrated motor recovery in two of four paralyzed patients with clean one-year safety record